Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Rund

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|October 25, 2021
Laboratory diagnosis of iron deficiency: look out for the 'PITTs'Deborah Rund
Leukemia & Lymphoma|December 11, 2007
FLT3 internal tandem duplication in low risk MDS: clinical and basic science relevanceDeborah Rund
Leukemia & Lymphoma|March 27, 2013
Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCsDeborah Rund
Leukemia & Lymphoma|August 19, 2007
Hyperforin modulation of drug resistance: saint or sinner?Deborah Rund
Leukemia & Lymphoma|June 27, 2009
'Rapping' on the door of drug resistanceDeborah Rund
Leukemia & Lymphoma|January 15, 2016
Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answersDeborah Rund
British Journal of Haematology|November 20, 2020
Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?Deborah Rund
British Journal of Haematology|October 23, 2020
The evolution of clinical research in thalassaemia: where has all the funding gone?Deborah Rund
Leukemia & Lymphoma|May 24, 2011
Genotyping chronic lymphocytic leukemia in China: East meets WestDeborah Rund
British Journal of Haematology|May 23, 2019
Cognition in thalassaemia: the next milestoneDeborah Rund
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|October 25, 2021
Laboratory diagnosis of iron deficiency: look out for the 'PITTs'Deborah Rund
Leukemia & Lymphoma|December 11, 2007
FLT3 internal tandem duplication in low risk MDS: clinical and basic science relevanceDeborah Rund
Leukemia & Lymphoma|March 27, 2013
Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCsDeborah Rund
Leukemia & Lymphoma|August 19, 2007
Hyperforin modulation of drug resistance: saint or sinner?Deborah Rund
Leukemia & Lymphoma|June 27, 2009
'Rapping' on the door of drug resistanceDeborah Rund
Leukemia & Lymphoma|January 15, 2016
Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answersDeborah Rund
British Journal of Haematology|November 20, 2020
Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?Deborah Rund
British Journal of Haematology|October 23, 2020
The evolution of clinical research in thalassaemia: where has all the funding gone?Deborah Rund
Leukemia & Lymphoma|May 24, 2011
Genotyping chronic lymphocytic leukemia in China: East meets WestDeborah Rund
British Journal of Haematology|May 23, 2019
Cognition in thalassaemia: the next milestoneDeborah Rund
Pageof 7